Quintiles, Inc. Announces Exercise Of The Underwriters’ Option To Purchase Additional Secondary Shares

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles today announced that the underwriters of the previously announced secondary public offering of 15 million shares of its common stock have exercised in full their option to purchase an additional 2.25 million shares from certain shareholders of Quintiles. After giving effect to the sale of the additional shares, which was completed on March 26, 2014, the selling shareholders sold a total of 17,250,000 shares of Quintiles’ common stock in the offering at a price to the public of $52.00 per share.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC